MedPath

TERAZOL 3 DUAL PAK

TERAZOL 3 DUAL PAK

Discontinued
DIN Number

02130874

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02130874
AIG Number0236585001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G01AG02 TERCONAZOLE
Product Specifications
Dosage FormCream ,  Ovule ,  Kit
Route of AdministrationVaginal
AHFS Classification84:04.08.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

TERCONAZOLEActive
Strength: 0.8 %
Monograph: TERCONAZOLE
TERCONAZOLEActive
Strength: 80 MG
Monograph: TERCONAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.